Correlation Between TENCNT and Esperion Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TENCNT and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TENCNT and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TENCNT 3975 11 APR 29 and Esperion Therapeutics, you can compare the effects of market volatilities on TENCNT and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TENCNT with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of TENCNT and Esperion Therapeutics.

Diversification Opportunities for TENCNT and Esperion Therapeutics

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between TENCNT and Esperion is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding TENCNT 3975 11 APR 29 and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and TENCNT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TENCNT 3975 11 APR 29 are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of TENCNT i.e., TENCNT and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between TENCNT and Esperion Therapeutics

Assuming the 90 days trading horizon TENCNT 3975 11 APR 29 is expected to under-perform the Esperion Therapeutics. But the bond apears to be less risky and, when comparing its historical volatility, TENCNT 3975 11 APR 29 is 4.91 times less risky than Esperion Therapeutics. The bond trades about -0.95 of its potential returns per unit of risk. The Esperion Therapeutics is currently generating about 0.4 of returns per unit of risk over similar time horizon. If you would invest  200.00  in Esperion Therapeutics on September 4, 2024 and sell it today you would earn a total of  110.00  from holding Esperion Therapeutics or generate 55.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy19.05%
ValuesDaily Returns

TENCNT 3975 11 APR 29  vs.  Esperion Therapeutics

 Performance 
       Timeline  
TENCNT 75 11 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TENCNT 3975 11 APR 29 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Bond's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for TENCNT 3975 11 APR 29 investors.
Esperion Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

TENCNT and Esperion Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TENCNT and Esperion Therapeutics

The main advantage of trading using opposite TENCNT and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TENCNT position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.
The idea behind TENCNT 3975 11 APR 29 and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data